Skip to main content
. 2021 Oct 13;43(4):2681–2692. doi: 10.1007/s10072-021-05633-0

Fig. 4.

Fig. 4

mNGS and PCR validation. mNGS in CSF sample from patient 1 revealed 34 unique reads of SHV1 with 2.43% coverage (A). mNGS in CSF sample from patient 2 found 29 unique reads of SHV1 with 2.55% coverage (B). PCR amplification with a 94 bp product of SHV1 further validated the results of mNGS (C)